Crossmark

The association between sociodemographic, clinical, and potentially preventive therapies with oxaliplatin-induced peripheral neuropathy in colorectal cancer patients

Crossref DOI link: https://doi.org/10.1007/s00520-023-07850-z

Published Online: 2023-06-09

Published Print: 2023-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hines, Robert B. https://orcid.org/0000-0001-7139-3102
Schoborg, Christopher

Sumner, Timothy

Zhu, Xiang

Elgin, Elizabeth A.

Zhang, Shunpu
Funding

Funding for this research was provided by:

National Institutes of Health (1 R03 CA241788-01A1, 1 R03 CA241788-01A1)
License Information

Text and Data Mining valid from 2023-06-09

Version of Record valid from 2023-06-09
More Information

Article History

Received: 8 February 2023

Accepted: 29 May 2023

First Online: 9 June 2023

Declarations

:

: As this was an observational study of a limited data set without any direct identifiers, this study was deemed exempt from institutional board review by the IRB at the University of Central Florida.

: This study was deemed exempt from IRB review. Thus, the requirement for informed consent requirement was waived.

: NA.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below